Clinical Trial Update: A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) [Phase 3]

View source ↗

Summary

A Phase 3 neoadjuvant trial (IMpower030) evaluating atezolizumab plus chemotherapy versus chemotherapy alone in resectable non-small cell lung cancer has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Small-Cell Lung | Phase 3 | Status: COMPLETED